SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-029988
Filing Date
2023-02-09
Accepted
2023-02-09 16:04:04
Documents
2
Group Members
ANSBERT GADICKEED HURWITZLUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV2018 LLCMPM BIOVENTURES 2018 (B), L.P.MPM BIOVENTURES 2018 GP LLCMPM BIOVENTURES 2018 LLCTODD FOLEY

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d423457dsc13ga.htm SC 13G/A 164630
2 EX-99.A d423457dex99a.htm EX-99.A 12846
  Complete submission text file 0001193125-23-029988.txt   179204
Mailing Address 450 KENDALL STREET CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET CAMBRIDGE MA 02142 617-425-9200
MPM BIOVENTURES 2018, L.P. (Filed by) CIK: 0001729505 (see all company filings)

IRS No.: 823687697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Subject) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91706 | Film No.: 23606153
SIC: 2834 Pharmaceutical Preparations